Literature DB >> 18191761

Risk factors for pediatric invasive pneumococcal disease in the Intermountain West, 1996-2002.

Maryam B Haddad1, Christina A Porucznik, Kerry E Joyce, Anindya K De, Andrew T Pavia, Robert T Rolfs, Carrie L Byington.   

Abstract

PURPOSE: In response to concerns that the epidemiology of pediatric invasive pneumococcal disease (IPD) in the Intermountain West (i.e., Utah, Idaho, Wyoming, Montana, and parts of Arizona and Nevada) was poorly understood and might differ from elsewhere in the United States, a case-control study was undertaken to determine factors associated with IPD during 1996-2002.
METHODS: A telephone questionnaire was administered to parents of children comprising 120 cases identified through hospital records and to parents of 156 age-matched controls located by random-digit dialing. The unit of analysis was each matched case-control set.
RESULTS: Underlying chronic illness was reported for 32 (27%) of the cases. For previously healthy children, breastfeeding had a protective benefit (adjusted odds ratio: 0.2; 95% confidence interval [CI], 0.1-0.6), while a history of tympanostomy tube surgery was a risk factor (adjusted odds ratio: 12.6; 95% CI, 1.5-107.3).
CONCLUSIONS: The presence of an underlying chronic illness was the strongest risk factor for IPD. Except for a history of tympanostomy tube surgery, the factors associated with IPD in this investigation were similar to those reported from other geographic regions. Tympanostomy surgery might serve as a surrogate indicator for predisposition to recurrent otitis media or decreased ability to clear pneumococcal infection, raising risk for invasive disease. Pediatric clinicians should continue to encourage breastfeeding, and continued emphasis on pneumococcal vaccination should help prevent IPD.

Entities:  

Mesh:

Year:  2008        PMID: 18191761     DOI: 10.1016/j.annepidem.2007.09.006

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  8 in total

1.  Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era.

Authors:  Krow Ampofo; Andrew T Pavia; Chris R Stockmann; Anne J Blaschke; Hsin Yi Cindy Weng; Kent E Korgenski; Judy Daly; Carrie L Byington
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

2.  Evolving epidemiologic characteristics of invasive group a streptococcal disease in Utah, 2002-2010.

Authors:  Chris Stockmann; Krow Ampofo; Adam L Hersh; Anne J Blaschke; Brian A Kendall; Kent Korgenski; Judy Daly; Harry R Hill; Carrie L Byington; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2012-04-24       Impact factor: 9.079

Review 3.  Association of secondhand smoke exposure with pediatric invasive bacterial disease and bacterial carriage: a systematic review and meta-analysis.

Authors:  Chien-Chang Lee; Nicole A Middaugh; Stephen R C Howie; Majid Ezzati
Journal:  PLoS Med       Date:  2010-12-07       Impact factor: 11.069

4.  Pneumococcal necrotizing pneumonia in Utah: does serotype matter?

Authors:  Jeffrey M Bender; Krow Ampofo; Kent Korgenski; Judy Daly; Andrew T Pavia; Edward O Mason; Carrie L Byington
Journal:  Clin Infect Dis       Date:  2008-05-01       Impact factor: 9.079

5.  Invasive pneumococcal disease in infants younger than 90 days before and after introduction of PCV7.

Authors:  Liset Olarte; Krow Ampofo; Chris Stockmann; Edward O Mason; Judy A Daly; Andrew T Pavia; Carrie L Byington
Journal:  Pediatrics       Date:  2013-06-03       Impact factor: 7.124

6.  Retrospective study of prognostic factors in pediatric invasive pneumococcal disease.

Authors:  Nan-Chang Chiu; Hsin Chi; Chun-Chih Peng; Hung-Yang Chang; Daniel Tsung-Ning Huang; Lung Chang; Wei-Te Lei; Chien-Yu Lin
Journal:  PeerJ       Date:  2017-01-25       Impact factor: 2.984

7.  Clinical characteristics and antimicrobial resistance of pneumococcal isolates of pediatric invasive pneumococcal disease in China.

Authors:  Kang Cai; Yizhong Wang; Zhongqin Guo; Xiaonan Xu; Huajun Li; Qingli Zhang
Journal:  Infect Drug Resist       Date:  2018-11-26       Impact factor: 4.003

Review 8.  The burden of invasive pneumococcal disease in children with underlying risk factors in North America and Europe.

Authors:  M A Rose; D Christopoulou; T T H Myint; I de Schutter
Journal:  Int J Clin Pract       Date:  2013-07-19       Impact factor: 2.503

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.